跳至主要内容
临床试验/NL-OMON21296
NL-OMON21296招募中不适用

Preoperative radiotherapy in patients at very high risk of postoperative pancreatic fistula after pancreatoduodenectomy (FIBROPANC): a multicenter phase II study

A0 个研究点目标入组 33 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
A
入组人数
33

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients scheduled to undergo pancreatoduodenectomy for another indication than pancreatic ductal adenocarcinoma.
  • - Pancreatic duct diameter = 3 millimetres, measured on the diagnostic CT scan (at the level of the portomesenteric vein, at the pancreatic neck, the future anastomotic site).
  • - WHO-ECOG performance status 0,1 or 2.
  • - Ability to undergo stereotactic radiotherapy and surgery.
  • - Age = 18 years.
  • - Good understanding of the oral and written patient information provided.
  • - Written informed consent.

排除标准

  • - Patients undergoing pancreatoduodenectomy for (suspected) pancreatic cancer, chronic pancreatitis, or benign neoplasms (e.g. serous cyst) in the periampullary region.
  • - Patients with a history of pancreatitis
  • - Contra-indications for MRI

研究者

发起方
A

相似试验